Transient impact of lenacapavir against MDR HIV-2 without other active ART
1 January 2025. Related: Antiretrovirals, Treatment strategies, Virology, Drug resistance.
Virology
ART in early infection stops further viral evolution
21 April 2024. Related: Antiretrovirals, Virology.
CROI 2021: HIV capsid uncoats in the CD4 nucleus rather than the cytoplasm – viral lifecycle updated…
12 March 2021. Related: Conference reports, Virology.
CROI 2020: Special session on COVID-19
12 March 2020. Related: Conference reports, Virology, COVID-19: pathogenesis, COVID-19: on the web.
One in five people with recent HIV infection in Spain have X4/R5 mixed tropic virus
25 July 2013. Related: Conference reports, Virology.
Low- and middle-income countries defuse hepatitis C
30 June 2013. Related: Pipeline report, Hepatitis coinfection, Virology.
Discord controllers: characterising a new viremic controller phenotype
1 October 2012. Related: Virology.
5th HIV Persistence Workshop on HIV Reservoirs, 6-9 December 2011, West Indies
1 February 2012. Related: Conference reports, Cure-related research, Basic science and immunology, Virology.
Workshop report and commentary: HIV persistence and reservoirs
1 February 2012. Related: Conference reports, Cure-related research, Basic science and immunology, Virology.
Virological findings from the SARA trial ofboosted protease inhibitor monotherapy
1 December 2010. Related: Conference reports, Antiretrovirals, Treatment access, Virology.
HIV reinfection cases reported at CROI
1 June 2010. Related: Conference reports, HIV prevention and transmission, Virology.
HIV viral dynamics: viral fitness, genetic diversity, progression, co-receptor use
1 October 2003. Related: Conference reports, Basic science and immunology, Virology.
Pulmonary hypertension: finally a treatment trial!
1 October 2003. Related: Conference reports, Virology.
Replicative capacity results complicated by minority wild-type virus
1 September 2003. Related: Conference reports, Virology, Drug resistance.
Animal retroviral infections suggest third kind of potential treatment: HIV harm reduction
1 December 2002. Related: Basic science and immunology, Virology.
A view from the lab: interview with Professor Clive Loveday
15 May 2000. Related: Virology, Activism & advocacy, Other news.